Oncology Information Systems Market Report 2025

The oncology information systems market size has grown strongly in recent years. It will grow from $3.05 billion in 2024 to $3.27 billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to increasing cancer incidence, growing emphasis on precision medicine, shift towards value-based care, regulatory compliance and reporting requirements, rise in cancer research and clinical trials, focus on streamlining workflow.

The oncology information systems market size is expected to see strong growth in the next few years. It will grow to $4.72 billion in 2029 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to integration with genomic data, population health management strategies, focus on cybersecurity in healthcare, patient engagement and education tools, regulatory changes and healthcare reforms. Major trends in the forecast period include advancements in medical imaging technologies, integration of electronic health records, artificial intelligence (AI) in oncology, remote patient monitoring and telemedicine, cybersecurity in healthcare, integration with wearable health technologies.

The growth of the oncology information systems market is anticipated to be propelled by the increasing global prevalence of cancer. Prevalence, in this context, denotes the number of individuals living with cancer. Oncology information systems play a crucial role in managing data and patient information, streamlining various aspects of cancer care, and handling cancer-related data within hospital settings. As reported by the American Cancer Society in January 2023, the number of cancer cases rose from 1,898,160 in 2021 to 1,958,310 in 2023, indicating a growth of 3.16%. Hence, the surge in the global prevalence of cancer is a significant driver for the oncology information systems market.

The oncology information systems market is expected to benefit from the growing adoption of healthcare IT. Healthcare IT adoption involves the integration and utilization of information technology solutions in the healthcare sector. Healthcare institutions are strategically investing in information technology, including electronic health records (EHRs) and clinical decision support systems (CDSS), to optimize patient care by seamlessly integrating real-time patient data, treatment guidelines, and alerts for potential issues, thereby enhancing outcomes in cancer treatment. In a report published by the Healthcare Information and Management Systems Society (HIMSS) in January 2022, a notable 80% of healthcare providers expressed plans to enhance their investments in technology and digital solutions over the next five years. Thus, the increasing adoption of healthcare IT is expected to drive the oncology information systems market.

Major companies in the oncology information systems market are pursuing collaborations aimed at developing a new radiation therapy simulation and treatment planning workflow solution. This initiative seeks to create personalized treatment plans that optimize radiation therapy delivery while minimizing exposure to healthy tissues. The partnership focuses on integrating RaySearch's RayStation treatment planning system with GE Healthcare’s multi-modality imaging systems, including CT, MR, and molecular imaging, to enhance the precision and efficiency of cancer treatment. For instance, in May 2022, GE HealthCare Technologies, Inc., a U.S.-based medical technology company, partnered with RaySearch Laboratories AB, a Sweden-based provider of software for radiation therapy. This collaboration aims to establish an interoperable and integrated workflow that streamlines the simulation process, ultimately optimizing clinical planning and operational outcomes for hospitals and cancer treatment centers.

Major companies in the market are concentrating on developing innovative products, such as cloud-based oncology analytics systems, to expand their customer base and gain a competitive advantage. A cloud-based oncology analytics system is a digital platform hosted on cloud infrastructure that provides advanced data analytics and insights tailored specifically for oncology treatment. In September 2023, RaySearch Laboratories unveiled its latest offerings, including the RayCare oncology information system and the cloud-based oncology analytics system, RayIntelligence. The upgraded version of RayCare introduces improved treatment schedules, enhanced support for data migration, and updates to patient chart and task management features. RayIntelligence, the cloud-based system, offers valuable features such as DICOM data import and new clinical goals dashboards.

In August 2023, Exor NV, a Netherlands-based company, acquired Philips Healthcare for $2.8 billion. This acquisition enables Exor to enhance its portfolio by leveraging Philips Healthcare's expertise in providing oncology information systems. Philips Healthcare NV is a hospital based in the Netherlands that specializes in oncology information systems.

Major companies operating in the oncology information systems market include Koninklijke Philips NV, Varian Medical Systems Inc., McKesson Corporation, Siemens Medical Solutions USA Inc., Elekta AB, Cerner Corporation, Flatiron Health Inc., Accuray Incorporated, CureMD Corporation, RaySearch Laboratories, Advanced Data Systems Corporation, Optum Inc., Allscripts Healthcare Solutions Inc., Altos Solutions Inc., AmerisourceBergen Corporation, athenahealth Inc., Candelis Inc., Carestream Health Inc., Change Healthcare, Computer Programs and Systems Inc., Epic Systems Corporation, GE Healthcare, IBM Corporation.

North America was the largest region in the oncology information system market in 2024. Asia-Pacific is expected to be the fastest-growing region in the oncology information system market report during the forecast period. The regions covered in the oncology information systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the oncology information systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Oncology information systems are software solutions designed to support the comprehensive management of information and images related to cancer. They play a crucial role in the management of cancer data and the monitoring of cancer care processes.

The major products within the realm of oncology information systems include solutions and professional services. The term 'solution' refers to a combination of software applications and services provided by suppliers, channel partners, and value-added resellers to clients. These information systems find application in various areas, including medical oncology, radiation oncology, and surgical oncology. They are utilized by diverse end-users such as hospitals and diagnostic imaging centers, ablation care centers, cancer care centers, government institutions, and research facilities.

The oncology information systems market research report is one of a series of new reports that provides oncology information systems market statistics, including oncology information systems industry global market size, regional shares, competitors with an oncology information systems market share, detailed oncology information systems market segments, market trends, and opportunities, and any further data you may need to thrive in the oncology information systems industry. This oncology information systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The oncology information systems market includes revenues earned by entities by providing clinical trial protocol management, drug inventory management, toxicity assessment, and survivorship care. The oncology information systems generally collects the data related to cancer treatment and care. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.